editorial | Q871232 |
scholarly article | Q13442814 |
P50 | author | Laura Formentini | Q42325549 |
P2093 | author name string | José M Cuezva | |
María Sánchez-Aragó | |||
Javier García-Bermúdez | |||
P2860 | cites work | The structure of bovine F1-ATPase in complex with its regulatory protein IF1 | Q27641847 |
How the regulatory protein, IF1, inhibits F1-ATPase from bovine mitochondria | Q27648517 | ||
Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria | Q28593536 | ||
The ATP synthase--a splendid molecular machine | Q29617444 | ||
Transcriptional paradigms in mammalian mitochondrial biogenesis and function | Q29619590 | ||
Post-transcriptional regulation of the mitochondrial H(+)-ATP synthase: a key regulator of the metabolic phenotype in cancer | Q30155975 | ||
The tumor suppressor function of mitochondria: translation into the clinics. | Q37472327 | ||
The mitochondrial ATPase inhibitory factor 1 triggers a ROS-mediated retrograde prosurvival and proliferative response | Q39395452 | ||
Up-regulation of the ATPase inhibitory factor 1 (IF1) of the mitochondrial H+-ATP synthase in human tumors mediates the metabolic shift of cancer cells to a Warburg phenotype. | Q39694624 | ||
Assessing actual contribution of IF1, inhibitor of mitochondrial FoF1, to ATP homeostasis, cell growth, mitochondrial morphology, and cell viability | Q42182860 | ||
P433 | issue | 16 | |
P1104 | number of pages | 2 | |
P304 | page(s) | 2963-2964 | |
P577 | publication date | 2012-08-08 | |
P1433 | published in | Cell Cycle | Q1254166 |
P1476 | title | IF1 reprograms energy metabolism and signals the oncogenic phenotype in cancer | |
P478 | volume | 11 |
Q36958409 | ATPase inhibitory factor 1 expression is an independent prognostic factor in non-small cell lung cancer |
Q35620290 | Changes in glycoprotein expression between primary breast tumour and synchronous lymph node metastases or asynchronous distant metastases |
Q30837218 | Energy metabolism and metabolic sensors in stem cells: the metabostem crossroads of aging and cancer |
Q36809594 | Expression, regulation and clinical relevance of the ATPase inhibitory factor 1 in human cancers |
Q38358175 | Hitting the Bull's-Eye in Metastatic Cancers-NSAIDs Elevate ROS in Mitochondria, Inducing Malignant Cell Death. |
Q28081608 | Metabolic control of cancer cell stemness: Lessons from iPS cells |
Q89474868 | Overexpression of native IF1 downregulates glucose-stimulated insulin secretion by pancreatic INS-1E cells |
Q38973743 | Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis. |
Q55172169 | Reduction of the ATPase inhibitory factor 1 (IF1) leads to visual impairment in vertebrates. |
Q41831013 | The Warburg effect version 2.0: metabolic reprogramming of cancer stem cells |
Q38071479 | The mitochondrial H(+)-ATP synthase and the lipogenic switch: new core components of metabolic reprogramming in induced pluripotent stem (iPS) cells. |
Search more.